Cardiovascular disease is the leading cause of death in women, and stress-related psychiatric disorders are considered cardiovascular risk factors in their own right. Hormonal contraceptives, which are used by around 9 million women in the USA, have a heterogeneous cardiovascular effect profile. A retrospective cohort study published in JAMA Network Open in January 2026 is the first to systematically investigate how post-traumatic stress disorder (PTSD), depression and anxiety disorders influence the association between combined hormonal contraception and serious cardiovascular events and deep vein thrombosis.
You May Also Like
- White and Black Skin Cancer
Biology and Modern Therapeutic Approaches
- Highlights from the AAD Annual Meeting
Atopic Dermatitis: Interesting News on Drug Candidates in Phase III
- Autoimmune Liver Diseases
Innovative Treatment Approaches for PBC, PSC, and AIH: What’s New?
- Myelofibrosis
Mutations and Molecular Diagnostics in Treatment Decisions
- Psoriasis in the Age of Precision Medicine
Systemic Therapy for Patients with Comorbidities: What Is the Best Choice?
- The AMALFI study and the limits of digital screening for atrial fibrillation
Remote monitoring for atrial fibrillation: lots of detection, little stroke prevention?
- MASH
Pharmacotherapies as “Game Changers”—What Are the Upcoming Challenges?
- Obesity Treatment